In today, Chinese subsidiary is valued at AU$20 mil (US$5 mil for 30%), cash (not including US$5 mil) around $12 mil. That's already the market cap at current price.
CEO bought 433k shares at average 14.9c though he had 135 mil shares already.
share price could go much higher once:
Jacket - CE & FDA approval ~ 1H’2017
GMP – CE & FDA approval ~ 2H’2017